List of Tables
Table 1. Global Synthetic Peptide Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Synthetic Peptide Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Synthetic Peptide Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Synthetic Peptide Vaccine Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Synthetic Peptide Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Synthetic Peptide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Synthetic Peptide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Synthetic Peptide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Synthetic Peptide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Peptide Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Synthetic Peptide Vaccine Sales by Region (2020-2025) & (K Dose)
Table 18. Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Synthetic Peptide Vaccine Sales by Region (2026-2031) & (K Dose)
Table 20. Global Synthetic Peptide Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Synthetic Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Synthetic Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Synthetic Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Synthetic Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
Table 27. North America Synthetic Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
Table 28. North America Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Synthetic Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Synthetic Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
Table 32. Europe Synthetic Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
Table 33. Europe Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Synthetic Peptide Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Synthetic Peptide Vaccine Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific Synthetic Peptide Vaccine Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific Synthetic Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Synthetic Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Synthetic Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Synthetic Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America Synthetic Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Synthetic Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa Synthetic Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Synthetic Peptide Vaccine Sales (K Dose) by Type (2020-2025)
Table 51. Global Synthetic Peptide Vaccine Sales (K Dose) by Type (2026-2031)
Table 52. Global Synthetic Peptide Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Synthetic Peptide Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Synthetic Peptide Vaccine Price (US$/Dose) by Type (2020-2025)
Table 59. Global Synthetic Peptide Vaccine Price (US$/Dose) by Type (2026-2031)
Table 60. Global Synthetic Peptide Vaccine Sales (K Dose) by Application (2020-2025)
Table 61. Global Synthetic Peptide Vaccine Sales (K Dose) by Application (2026-2031)
Table 62. Global Synthetic Peptide Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Synthetic Peptide Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Synthetic Peptide Vaccine Price (US$/Dose) by Application (2020-2025)
Table 69. Global Synthetic Peptide Vaccine Price (US$/Dose) by Application (2026-2031)
Table 70. Anergis Company Information
Table 71. Anergis Description and Business Overview
Table 72. Anergis Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Anergis Synthetic Peptide Vaccine Product
Table 74. Anergis Recent Developments/Updates
Table 75. Antigen Express Company Information
Table 76. Antigen Express Description and Business Overview
Table 77. Antigen Express Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Antigen Express Synthetic Peptide Vaccine Product
Table 79. Antigen Express Recent Developments/Updates
Table 80. Apitope Technology Company Information
Table 81. Apitope Technology Description and Business Overview
Table 82. Apitope Technology Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Apitope Technology Synthetic Peptide Vaccine Product
Table 84. Apitope Technology Recent Developments/Updates
Table 85. Artificial Cell Technologies Company Information
Table 86. Artificial Cell Technologies Description and Business Overview
Table 87. Artificial Cell Technologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Artificial Cell Technologies Synthetic Peptide Vaccine Product
Table 89. Artificial Cell Technologies Recent Developments/Updates
Table 90. Benovus Bio Company Information
Table 91. Benovus Bio Description and Business Overview
Table 92. Benovus Bio Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Benovus Bio Synthetic Peptide Vaccine Product
Table 94. Benovus Bio Recent Developments/Updates
Table 95. Celgene Corporation Company Information
Table 96. Celgene Corporation Description and Business Overview
Table 97. Celgene Corporation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Celgene Corporation Synthetic Peptide Vaccine Product
Table 99. Celgene Corporation Recent Developments/Updates
Table 100. Immatics biotechnologies Company Information
Table 101. Immatics biotechnologies Description and Business Overview
Table 102. Immatics biotechnologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Immatics biotechnologies Synthetic Peptide Vaccine Product
Table 104. Immatics biotechnologies Recent Developments/Updates
Table 105. Merck Company Information
Table 106. Merck Description and Business Overview
Table 107. Merck Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Merck Synthetic Peptide Vaccine Product
Table 109. Merck Recent Developments/Updates
Table 110. ImmunoCellular Therapeutics Company Information
Table 111. ImmunoCellular Therapeutics Description and Business Overview
Table 112. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product
Table 114. ImmunoCellular Therapeutics Recent Developments/Updates
Table 115. ISA Pharmaceuticals Company Information
Table 116. ISA Pharmaceuticals Description and Business Overview
Table 117. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. ISA Pharmaceuticals Synthetic Peptide Vaccine Product
Table 119. ISA Pharmaceuticals Recent Developments/Updates
Table 120. Lytix Biopharma Company Information
Table 121. Lytix Biopharma Description and Business Overview
Table 122. Lytix Biopharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Lytix Biopharma Synthetic Peptide Vaccine Product
Table 124. Lytix Biopharma Recent Developments/Updates
Table 125. Spotlight Innovation Company Information
Table 126. Spotlight Innovation Description and Business Overview
Table 127. Spotlight Innovation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Spotlight Innovation Synthetic Peptide Vaccine Product
Table 129. Spotlight Innovation Recent Developments/Updates
Table 130. OncoTherapy Science Company Information
Table 131. OncoTherapy Science Description and Business Overview
Table 132. OncoTherapy Science Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. OncoTherapy Science Synthetic Peptide Vaccine Product
Table 134. OncoTherapy Science Recent Developments/Updates
Table 135. Peptech Company Information
Table 136. Peptech Description and Business Overview
Table 137. Peptech Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Peptech Synthetic Peptide Vaccine Product
Table 139. Peptech Recent Developments/Updates
Table 140. Pharmasyntez Company Information
Table 141. Pharmasyntez Description and Business Overview
Table 142. Pharmasyntez Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 143. Pharmasyntez Synthetic Peptide Vaccine Product
Table 144. Pharmasyntez Recent Developments/Updates
Table 145. Sumitomo Dainippon Pharma Company Information
Table 146. Sumitomo Dainippon Pharma Description and Business Overview
Table 147. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 148. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product
Table 149. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 150. TapImmune Company Information
Table 151. TapImmune Description and Business Overview
Table 152. TapImmune Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 153. TapImmune Synthetic Peptide Vaccine Product
Table 154. TapImmune Recent Developments/Updates
Table 155. Targovax Company Information
Table 156. Targovax Description and Business Overview
Table 157. Targovax Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 158. Targovax Synthetic Peptide Vaccine Product
Table 159. Targovax Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Synthetic Peptide Vaccine Distributors List
Table 163. Synthetic Peptide Vaccine Customers List
Table 164. Synthetic Peptide Vaccine Market Trends
Table 165. Synthetic Peptide Vaccine Market Drivers
Table 166. Synthetic Peptide Vaccine Market Challenges
Table 167. Synthetic Peptide Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Synthetic Peptide Vaccine
Figure 2. Global Synthetic Peptide Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Synthetic Peptide Vaccine Market Share by Type: 2024 & 2031
Figure 4. Solution Phase Synthesis (SPS) Product Picture
Figure 5. Solid Phase Peptide Synthesis (SPPS) Product Picture
Figure 6. Global Synthetic Peptide Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Synthetic Peptide Vaccine Market Share by Application: 2024 & 2031
Figure 8. Prostate Cancer
Figure 9. Breast Cancer
Figure 10. Gastric Cancer
Figure 11. Lung Cancer
Figure 12. Pancreatic Cancer
Figure 13. Others
Figure 14. Global Synthetic Peptide Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Synthetic Peptide Vaccine Market Size (2020-2031) & (US$ Million)
Figure 16. Global Synthetic Peptide Vaccine Sales (2020-2031) & (K Dose)
Figure 17. Global Synthetic Peptide Vaccine Average Price (US$/Dose) & (2020-2031)
Figure 18. Synthetic Peptide Vaccine Report Years Considered
Figure 19. Synthetic Peptide Vaccine Sales Share by Manufacturers in 2024
Figure 20. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Synthetic Peptide Vaccine Players: Market Share by Revenue in Synthetic Peptide Vaccine in 2024
Figure 22. Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Synthetic Peptide Vaccine Sales Market Share by Country (2020-2031)
Figure 25. North America Synthetic Peptide Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. United States Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Synthetic Peptide Vaccine Sales Market Share by Country (2020-2031)
Figure 29. Europe Synthetic Peptide Vaccine Revenue Market Share by Country (2020-2031)
Figure 30. Germany Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Synthetic Peptide Vaccine Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2031)
Figure 37. China Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Synthetic Peptide Vaccine Sales Market Share by Country (2020-2031)
Figure 47. Latin America Synthetic Peptide Vaccine Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Synthetic Peptide Vaccine Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Synthetic Peptide Vaccine Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Synthetic Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Synthetic Peptide Vaccine by Type (2020-2031)
Figure 57. Global Revenue Market Share of Synthetic Peptide Vaccine by Type (2020-2031)
Figure 58. Global Synthetic Peptide Vaccine Price (US$/Dose) by Type (2020-2031)
Figure 59. Global Sales Market Share of Synthetic Peptide Vaccine by Application (2020-2031)
Figure 60. Global Revenue Market Share of Synthetic Peptide Vaccine by Application (2020-2031)
Figure 61. Global Synthetic Peptide Vaccine Price (US$/Dose) by Application (2020-2031)
Figure 62. Synthetic Peptide Vaccine Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
